홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
ALT
#3034
Altimmune, Inc. Common Stock
3.2
9
USD
+1.86%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+1.86%
월간 변동
-8.61%
6달 변화
-17.34%
년간 변동율
-28.17%
이전 종가
3.2
3
Open
3.2
9
Bid
Ask
Low
3.2
9
High
3.2
9
양
77
마켓
주식
헬스케어
ALT
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
37.15 M
43.22 M
49.28 M
70.9 M
77.01 M
130.07 M
—
Valuation ratios
Enterprise value
306.79 M
208.61 M
664.84 M
610.7 M
518.34 M
461.48 M
1.34 B
Price to earnings ratio
—
-3.9
-8.64
-6.34
-5.38
-3.61
-14.38
Price to sales ratio
—
85.74
-10.79 K
1 314.92
25.6 K
7 757.46
55.05 K
Price to cash flow ratio
—
-4.83
-11.72
-7.39
-6.41
-4.71
-17.14
Price to book ratio
—
1.9
3.96
2.89
4.14
1.41
3.08
EBITDA 비율에 대한 기업 가치
-5.56
-2.13
-7.56
-6.24
-4.85
-4.42
-13.16
Profitability ratios
Return on assets %
-0.2
-0.44
-0.41
-0.42
-0.68
-0.31
-0.43
Return on equity %
-0.22
-0.49
-0.46
-0.46
-0.77
-0.39
-0.5
Return on invested capital %
-1 240.11
-1 610.96
-1 362.31
-2 511.47
—
-4 444.59
-4 768.99
Gross margin %
100
100
100
100
100
100
400
Operating margin %
-669.5
-2 197.42
129.03 K
-22.52 K
-515.86 K
-230.46 K
-1.42 M
EBITDA margin %
-665.86
-2 184.92
128.29 K
-22.99 K
-533.92 K
-234.73 K
-1.45 M
Net margin %
-599.2
-2 201.43
124.58 K
-20.76 K
-475.29 K
-214.86 K
-1.32 M
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
19.16
11.17
11.31
17.26
13.11
18.55
72.02
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.05
0.02
-0
0
0
0
0
Solvency ratios
Debt to assets ratio
0.01
0.01
0.03
—
—
0.13
—
Debt to equity ratio
0.02
0.02
0.03
—
—
0.16
—
Long term debt to total assets ratio
0.01
0.01
0.02
—
—
0.12
—
Long term debt to total equity ratio
0.01
0.01
0.02
—
—
0.15
—
Per share metrics
Operating cash flow per share
—
-1.9
-1.33
-1.42
-1.12
-0.77
-0.81
EBIT per share
—
-2.35
-1.87
-1.8
-1.45
-1.07
-1.13
EBITDA per share
—
-2.33
-1.86
-1.84
-1.5
-1.09
-1.15
Total debt per share
—
0.07
0.12
—
—
0.41
—
Cash per share
—
4.61
3.94
3.72
1.86
3.1
9.69
Net current asset value per share
—
4.94
4.11
3.94
1.93
3.16
9.95
Tangible book value per share
—
4.52
3.68
3.65
1.74
2.55
8.49
Working capital per share
—
4.5
3.75
3.71
1.79
2.99
9.39
Book value per share
—
4.82
3.95
3.65
1.74
2.55
8.49
뉴스
ALT Stock and the 2026 MASH Race: Dual Agonists vs. New Mechanisms
Altimmune Stock: Neutral Outlook With Big 2026 Catalysts
ALT Pemvidutide Explained: What Makes It Different in MASH
알티뮨, MASH 집중으로 H.C. Wainwright 목표 주가 상향
H.C. Wainwright raises Altimmune stock price target on MASH focus
Altimmune, Pemvidutide 잠재력 발표 (Barclays 컨퍼런스)
Altimmune at Barclays Conference: Advancing Pemvidutide’s Potential
Altimmune, MASH 치료 전략 발전 발표
Altimmune at Leerink Conference: Strategic Advances in MASH Treatment
알티뮨 CEO, 70,790달러 상당 자사주 매입
Altimmune CEO Durso buys $70,790 in shares
알티뮨 CFO Weaver, 2300만원 상당 주식 매입